Santhera Pharmaceuticals
Works in Genetic & rare · GI & liver · Metabolic & endocrine · Musculoskeletal · Neurology · Ophthalmology · Respiratory
Santhera Pharmaceuticals is a clinical trial sponsor. It has 1 active clinical trial with 80 planned participants, across 7 therapeutic areas. Since 2021 it has completed 9 trials and stopped 2 early.
Trial track record · since 2021
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Santhera Pharmaceuticals
Santhera Pharmaceuticals is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 80 planned participants, in Genetic & rare, GI & liver, Metabolic & endocrine, Musculoskeletal and other areas. Since 2021 it has completed 9 trials and stopped 2 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Santhera Pharmaceuticals; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-04-23.
Approve Suite is not affiliated with Santhera Pharmaceuticals. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.